Climb Bio Inc <CLYM.O>: RBC initiates coverage with Outperform rating; target price $23
CLYM•Related News
Euro zone yields edge up as investors watch Hormuz, await US data
TLT•
Miller Industries Inc <MLR.N>: D.A. Davidson Raises Target Price to $64 From $56
MLR•
Howmet Aerospace <HWM.N>: Jefferies raises target price to $370 from $340
HWM•
Aflac Incorporated <AFL.N>: Jefferies raises target price to $112 from $108
AFL•
Oil steady as Iran tempers hopes for swift Hormuz reopening
XLE•